These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25488055)

  • 1. Reference datasets for bioequivalence trials in a two-group parallel design.
    Fuglsang A; Schütz H; Labes D
    AAPS J; 2015 Mar; 17(2):400-4. PubMed ID: 25488055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studies.
    Schütz H; Labes D; Fuglsang A
    AAPS J; 2014 Nov; 16(6):1292-7. PubMed ID: 25212768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding Limits.
    Schütz H; Labes D; Tomashevskiy M; la Parra MG; Shitova A; Fuglsang A
    AAPS J; 2020 Feb; 22(2):44. PubMed ID: 32034551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential bioequivalence approaches for parallel designs.
    Fuglsang A
    AAPS J; 2014 May; 16(3):373-8. PubMed ID: 24526610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced Designs.
    Morales-Alcelay S; de la Torre de Alvarado JM; García-Arieta A
    AAPS J; 2015 Jul; 17(4):1033-4. PubMed ID: 25787313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approximate confidence limit for the reference scaled bioequivalence with a parallel design.
    Liao JJZ; Li Y
    J Biopharm Stat; 2020 Mar; 30(2):231-243. PubMed ID: 31455199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint equivalence of means and variances of two populations.
    Grieve AP
    J Biopharm Stat; 1998 Jul; 8(3):377-90. PubMed ID: 9741854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot and Repeat Trials as Development Tools Associated with Demonstration of Bioequivalence.
    Fuglsang A
    AAPS J; 2015 May; 17(3):678-83. PubMed ID: 25732246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified Wald test for reference scaled assessment of analytical equivalence.
    Weng YT; Tsong Y; Shen M; Wang C
    J Biopharm Stat; 2019; 29(6):1068-1081. PubMed ID: 30829123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the evaluation of individual bioequivalence.
    Endrenyi L
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carryover negligibility and relevance in bioequivalence studies.
    Ocaña J; Sanchez O MP; Carrasco JL
    Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs.
    Jaki T; Pallmann P; Wolfsegger MJ
    Stat Med; 2013 Dec; 32(30):5469-83. PubMed ID: 23801551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and inference for 3-stage bioequivalence testing with serial sampling data.
    Yan F; Zhu H; Liu J; Jiang L; Huang X
    Pharm Stat; 2018 Sep; 17(5):458-476. PubMed ID: 29726096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach for comparing means of two groups without equal variance assumption.
    Wang H; Chow SC
    Stat Med; 2002 Oct; 21(20):3137-51. PubMed ID: 12369087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency estimator for assessing of follow-on biologics.
    Lu Y; Zhang ZZ; Chow SC
    J Biopharm Stat; 2014; 24(6):1280-97. PubMed ID: 25072640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On sample size calculation in bioequivalence trials.
    Chow SC; Wang H
    J Pharmacokinet Pharmacodyn; 2001 Apr; 28(2):155-69. PubMed ID: 11381568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of four different methods for outlier detection in bioequivalence studies.
    Ramsay T; Elkum N
    J Biopharm Stat; 2005; 15(1):43-52. PubMed ID: 15702604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.